FIRE AB

From STAT on Dec 19

“Pfizer is this year’s anti-Eli Lilly. If David Ricks is the best biopharma CEO of 2023, then Pfizer CEO Albert Bourla is, unfortunately, the worst.

My annual Worst Biopharma CEO list is typically populated with blockheads and scoundrels. That’s not why Bourla is here. The reason is accountability. Strategic missteps, financial miscalculations, and scientific setbacks have plunged Pfizer into a deep crisis. Bourla is the man at the top, so the responsibility lies with him.”

Finally AB earns an appropriate spot on a bio pharma list. Unfortunately it is a “worst of” list and is a completely earned position. Hope the board takes some time to reflect on a 50% loss of value, stock at a decade low and their CEO recognized as the worst in bio pharma.

Opa!!

WSJ knows, too. They published an article that Pfizer needs to right the ship. The article lists failures, missed opportunities and leadership miscues. The Journal knows, investors know. Just our leadership and board in denial, preparing to dispense rich rewards to the sorry crew
 




will be interesting to see his LinkedIn post on being recognized as the worst bio pharma CEO.
Next book is Rim Shot How to be the Best of the Worst


Im going to go all caps here

ITS A MISTAKE TO BELIEVE THAT OUR CURRENT CEO IS OUR ONLY PROBLEM. SOMEONE NEEDS TO COME IN FROM THE OUTSIDE AND PULL A "JACK WELCH" RANK & YANK, from C-suite down to the manager level.
 












Im going to go all caps here

ITS A MISTAKE TO BELIEVE THAT OUR CURRENT CEO IS OUR ONLY PROBLEM. SOMEONE NEEDS TO COME IN FROM THE OUTSIDE AND PULL A "JACK WELCH" RANK & YANK, from C-suite down to the manager level.
agree completely, others like Sussman who have pushed the company to focus on social issues rather than business need to go as well. They like to write books touting their "leadership', then the other c-suite cronies push each others books on social media.
 




agree completely, others like Sussman who have pushed the company to focus on social issues rather than business need to go as well. They like to write books touting their "leadership', then the other c-suite cronies push each others books on social media.
When things are going smoothly here, all kinds of shenanigans take hold. The behaviors that you frequently describe are a small contributor. The larger issue is the lack of vision at almost all levels. And of course, since this is Pfizer, rampant cronyism when selecting said leaders and managers.
 












how much $ has the respective products brought in? what is the return on the investment?
barbershop-coming.gif
 




Angela made some really bad decisions. But let’s be honest, she was protected. The whole Connect thing was her baby. We couldn’t call the baby ugly on her watch so we had to live with it. With her gone, I see it going away sooner than later.
 




Angela made some really bad decisions. But let’s be honest, she was protected. The whole Connect thing was her baby. We couldn’t call the baby ugly on her watch so we had to live with it. With her gone, I see it going away sooner than later.
Wasn’t she also responsible for establishing the Derm division?
 








Angela made some really bad decisions. But let’s be honest, she was protected. The whole Connect thing was her baby. We couldn’t call the baby ugly on her watch so we had to live with it. With her gone, I see it going away sooner than later.

yep, she thought what worked for telephone sales reps in vaccines would transfer to other office types. Either she was fooled by her vaccines toadies like schutta or none of them understood the difference between selling a tangible need like a vaccine and other types of pharma products.

BTW, telephone sales only worked in pediatric offices for direct orders.
 












Angela made some really bad decisions. But let’s be honest, she was protected. The whole Connect thing was her baby. We couldn’t call the baby ugly on her watch so we had to live with it. With her gone, I see it going away sooner than later.

The Connect project never should have seen the light of day. It was comical when they said "this is what customers are asking for." The "leaders" that rolled out the concept, and sold it to the field as "next level sales", quickly moved into other roles. And, to have PharmD's available to answer customers questions...bahahahah. This was sold as a "Bold Move"...someone needs to admit it was a mistake and roll up the carpets on this one.